Table 5.
The prevalence of antihypertensive medication use, and use of specific antihypertensive classes in 6,088 participants from the 5th visit of the Atherosclerosis Risk in Communities Study, 2011–13.
| Antihypertensive Medication | All (n=6,088) | Whites (n=4,676) | Blacks (n=1,412) |
|---|---|---|---|
| Any Antihypertensive, % | 4567 (75.0) | 3331 (71.2) | 1236 (87.5) |
| ≥ 2 Antihypertensives, % | 2841 (46.7) | 1953 (41.8) | 888 (62.9) |
| ≥ 3 Antihypertensives, % | 1129 (18.5) | 746 (16.0) | 382 (27.1) |
|
| |||
| ACE-Inhibitor or ARB, % | 2822 (46.4) | 2027 (43.4) | 795 (56.3) |
| Calcium Channel Blocker, % | 1423 (23.3) | 887 (19.0) | 536 (38.0) |
| Diuretic, % | 1971 (32.4) | 1296 (27.7) | 675 (47.8) |
| Beta-Blocker, % | 2079 (34.2) | 1662 (35.5) | 417 (29.5) |
| Other* | 548 (9.0) | 364 (7.8) | 184 3.0) |
Abbreviations ACE – Angiotensin Converting Enzyme, ARB – Angiotensin Receptor Blocker.
*
Other antihypertensive medications include: Hydralazine, Clonidine, and Alpha-blockers